vimarsana.com
Home
Live Updates
Marvel Biosciences Announces Positive Interim Results on Tau Phosphorylation with MB-204 : comparemela.com
Marvel Biosciences Announces Positive Interim Results on Tau Phosphorylation with MB-204
Marvel Biosciences Corp. , and its wholly owned subsidiary, Marvel Biotechnology Inc. , today reported promising interim results from its acute study on MB-204 conducted by Professor Emmanuel Planel...
Related Keywords
Mark Williams ,
Emmanuel Planel ,
Marvel Biotechnology Inc ,
Regulation Services Provider ,
Alberta Newsfile Corp ,
Laval University ,
Marvel Biosciences Corp ,
Venture Exchange ,
Company Or Marvel ,
Marvel Biotechnology ,
Professor Emmanuel Planel ,
Abnormal Tau ,
Chronic Traumatic Encephalopathy ,
Biosciences Corp ,
Chief Executive Officer ,
Chief Science ,
Markets ,
comparemela.com © 2020. All Rights Reserved.